Fluoroscopy-guided percutaneous PFO closure achieved 96% freedom from recurrent embolic events at 10 years; presence of a residual shunt was a risk factor for recurrence (HR 3.4; 95% CI 1.3-9.2).
Cohort (n=525)
No
Does fluoroscopy-guided percutaneous PFO closure prevent recurrent embolic events in patients with cryptogenic stroke?
Fluoroscopy-guided percutaneous PFO closure without intraprocedural echocardiography is safe and provides long-term freedom from recurrent embolic events in patients with cryptogenic stroke.
Hazard Ratio: 3.4 (95% CI 1.3–9.2)
OBJECTIVES: To carry out long-term follow-up after percutaneous closure of patent foramen ovale (PFO) in patients with cryptogenic stroke. DESIGN: Prospective cohort study. SETTING: Single tertiary care centre. PARTICIPANTS: 525 consecutive patients (mean (SD) age 51 (12) years; 56% male). INTERVENTIONS: Percutaneous PFO closure without intraprocedural echocardiography. MAIN OUTCOME MEASURES: Freedom from recurrent embolic events. RESULTS: A mean (SD) of 1.7 (1.0) clinically apparent embolic events occurred for each patient, and 186 patients (35%) had >1 event. An atrial septal aneurysm was associated with the PFO in 161 patients (31%). All patients were followed up prospectively for up to 11 years. The implantation procedure failed in two patients (0.4%). There were 13 procedural complications (2.5%) without any long-term sequelae. Contrast transoesophageal echocardiography at 6 months showed complete closure in 86% of patients, and a minimal, moderate or large residual shunt in 9%, 3% and 2%, respectively. Patients with small occluders (<30 mm; n = 429) had fewer residual shunts (small 11% vs large 27%; p<0.001). During a mean (SD) follow-up of 2.9 (2.2) years (median 2.3 years; total 1534 patient-years), six ischaemic strokes, nine transient ischaemic attacks (TIAs) and two peripheral emboli occurred. Freedom from recurrent stroke, TIA, or peripheral embolism was 98% at 1 year, 97% at 2 years and 96% at 5 and 10 years, respectively. A residual shunt (hazard ratio = 3.4; 95% CI 1.3 to 9.2) was a risk factor for recurrence. CONCLUSIONS: This study attests to the long-term safety and efficacy of percutaneous PFO closure guided by fluoroscopy only for secondary prevention of paradoxical embolism in a large cohort of consecutive patients.
Wahl et al. (Mon,) conducted a cohort in Cryptogenic stroke with patent foramen ovale (n=525). Percutaneous PFO closure guided by fluoroscopy was evaluated on Freedom from recurrent embolic events (HR 3.4, 95% CI 1.3-9.2). Fluoroscopy-guided percutaneous PFO closure achieved 96% freedom from recurrent embolic events at 10 years; presence of a residual shunt was a risk factor for recurrence (HR 3.4; 95% CI 1.3-9.2).